Global Pharma Tek Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Global Pharma Tek's estimated annual revenue is currently $50.7M per year.(i)
  • Global Pharma Tek's estimated revenue per employee is $201,000

Employee Data

  • Global Pharma Tek has 252 Employees.(i)
  • Global Pharma Tek grew their employee count by 8% last year.

Global Pharma Tek's People

NameTitleEmail/Phone
1
Director OperationsReveal Email/Phone
2
Global Chief Human Resources Officer (CHRO)Reveal Email/Phone
3
Senior Clinical Data ManagerReveal Email/Phone
4
Business Development ManagerReveal Email/Phone
5
Business Development ManagerReveal Email/Phone
6
General Manager- Global Business DevelopmentReveal Email/Phone
7
Talent AcquisitionReveal Email/Phone
8
Business Development ManagerReveal Email/Phone
9
Senior Talent Acquisition SpecialistReveal Email/Phone
10
Business Development ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Global Pharma Tek?

keywords:N/A

N/A

Total Funding

252

Number of Employees

$50.7M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Global Pharma Tek News

2022-04-19 - Counterfeit Drug Detection Device Market To See Booming ...

Advanced Systems Development, Inc., B&W Tek., Centice Corporation, Consumer Physics, Global Pharma HealthCare Ltd., Olympus Corporation, PharmaSecure Inc.,...

2022-03-30 - Global Pharma Tek and Capleo Global Announce India Expansion with New Office in Hyderabad and on Hiring Spree

Global Pharma Tek (GPT) is one of the leading service provider conglomerates in Workforce Solutions, Clinical Research, and Trading. The opening...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A25221%N/A
#2
$15M25210%N/A
#3
$15M252-2%N/A
#4
$80.4M252-3%N/A
#5
$33.3M252N/AN/A